Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BTM002 versus Hyruan ONE for knee osteoarthritis pain
CTR20243807Phase 3Active
- Sponsor
- SciVision Biotech
- Start
- Feb 2026
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of HYAJOINT Plus in knee osteoarthritis (OA), sponsored by SciVision Biotech. Started Feb 2026; status: active.
02
Drugs
HYAJOINT Plus
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20243807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243807.